Target intelligence / Profile preview

Intrinsic apoptotic pathway proteins

Molecular classification
Enzyme (caspases, e.g. caspase-9), Adapter protein (Apaf-1), Regulatory protein (Bcl-2 family: pro-apoptotic and anti-apoptotic members), Inhibitor (IAPs: Inhibitor of Apoptosis Proteins, e.g. XIAP, survivin), Mitochondrial protein (cytochrome c)
01

Overview

Intrinsic apoptotic pathway proteins are a collective group of molecules that regulate and execute mitochondria-mediated apoptosis in response to cellular signals such as DNA damage, hypoxia, or oncogene activation. Key regulators include members of the Bcl-2 family (pro-apoptotic: BAX, BAK, BAD, BOK; anti-apoptotic: Bcl-2, Bcl-xL, Mcl-1), cytosolic proteins like Apaf-1, mitochondrial proteins such as cytochrome c, and executioner enzymes known as caspases (initiator caspase-9, effector caspase-3, caspase-7). Inhibitors of apoptosis (IAPs; e.g., XIAP, survivin) regulate caspase activity. The pathway is essential for normal development, tissue homeostasis, and elimination of damaged cells, with dysregulation linked to cancer, neurodegeneration, and other diseases. Individual proteins often serve as both biomarkers and therapeutic targets.

Other names
mitochondrial pathway of apoptosis proteinsintrinsic apoptosis proteinsmitochondrial apoptotic proteins
02

Mechanism of action

Bcl-2 inhibition increases mitochondrial permeability, triggers cytochrome c release; SMAC mimetics antagonize IAPs, allowing caspase activation; Caspase activation cleaves cellular substrates leading to apoptosis

03

Biological functions

Apoptosis (initiation and execution of cell death)Mitochondrial membrane permeabilizationCell fate determinationTumor suppression via p53 regulationDNA fragmentation (EndoG, AIF)
04

Disease associations

Cancer (dysregulation of intrinsic pathway; chemotherapy resistance)Neurodegenerative disease (inappropriate activation)Autoimmune diseaseCardiovascular disease (cell death in ischemia/hypoxia)
05

Safety considerations

Excessive apoptosis can cause tissue damage (e.g., neurodegeneration, cardiovascular disease)Inhibition of apoptosis can allow tumor survival/resistanceTherapies may induce off-target cell death, immune effects, or toxicity
06

Interacting drugs

Venetoclax (targets Bcl-2 proteins in cancer therapy)

3 more in the full profile.

07

Biomarkers

Ratio of BAX/Bcl-2 protein levels as prognostic or predictive markers in cancerMitochondrial cytochrome c release (diagnostic)Expression of p53 or IAPs (such as XIAP)

Beyond the preview

Go deeper on Intrinsic apoptotic pathway proteins.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Intrinsic apoptotic pathway proteins.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call